Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc J W van der Laan

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
New targets for treatment against HCV infectionQiuwei Pan, Luc J W van der Laan
Methods in Molecular Biology (Clifton, N.J.)|March 25, 2011
Production of multicopy shRNA lentiviral vectors for antiviral therapyScot D Henry, Quiwei Pan, Luc J W van der Laan
Nederlands Tijdschrift Voor Geneeskunde|July 29, 2025
[Clinical impact of microplastic exposure in humans]Willem Pieter Brouwer, Pengfei Li, Luc J W van der Laan
Advances in Experimental Medicine and Biology|March 12, 2015
Gene therapies for hepatitis C virusMonique M A Verstegen, Qiuwei Pan, Luc J W van der Laan
Bioengineering (Basel, Switzerland)|October 19, 2019
Bioengineering Liver TransplantationMonique M A Verstegen, Bart Spee, Luc J W van der Laan
BMC Biotechnology|August 7, 2021
Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluidsHenk P Roest, Jan N M IJzermans, Luc J W van der Laan
Journal of Virology|October 22, 2002
Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell linesArmin Ritzhaupt, Luc J W Van Der Laan, Daniel R Salomon, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Experimental models for hepatitis C viral infectionAndre Boonstra, Luc J W van der Laan, Thomas Vanwolleghem, et al.
Best Practice & Research. Clinical Gastroenterology|June 19, 2017
From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrixJorke Willemse, Ruby Lieshout, Luc J W van der Laan, et al.
Transplantation|March 25, 2008
Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?Ahmet Demirkiran, Thijs K Hendrikx, Carla C Baan, et al.
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
New targets for treatment against HCV infectionQiuwei Pan, Luc J W van der Laan
Methods in Molecular Biology (Clifton, N.J.)|March 25, 2011
Production of multicopy shRNA lentiviral vectors for antiviral therapyScot D Henry, Quiwei Pan, Luc J W van der Laan
Nederlands Tijdschrift Voor Geneeskunde|July 29, 2025
[Clinical impact of microplastic exposure in humans]Willem Pieter Brouwer, Pengfei Li, Luc J W van der Laan
Advances in Experimental Medicine and Biology|March 12, 2015
Gene therapies for hepatitis C virusMonique M A Verstegen, Qiuwei Pan, Luc J W van der Laan
Bioengineering (Basel, Switzerland)|October 19, 2019
Bioengineering Liver TransplantationMonique M A Verstegen, Bart Spee, Luc J W van der Laan
BMC Biotechnology|August 7, 2021
Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluidsHenk P Roest, Jan N M IJzermans, Luc J W van der Laan
Journal of Virology|October 22, 2002
Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell linesArmin Ritzhaupt, Luc J W Van Der Laan, Daniel R Salomon, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Experimental models for hepatitis C viral infectionAndre Boonstra, Luc J W van der Laan, Thomas Vanwolleghem, et al.
Best Practice & Research. Clinical Gastroenterology|June 19, 2017
From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrixJorke Willemse, Ruby Lieshout, Luc J W van der Laan, et al.
Transplantation|March 25, 2008
Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?Ahmet Demirkiran, Thijs K Hendrikx, Carla C Baan, et al.
Pageof 21